Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence

JAMA Psychiatry

Volumn 71, Issue 7, 2014, Pages 812-820

  Kohno, Milky ^a   Morales, Angelica M ^a   Ghahremani, Dara G ^a   Hellemann, Gerhard ^a   London, Edythe D ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BALLOON ANALOGUE RISK TASK; BRAIN FUNCTION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HIGH RISK BEHAVIOR; HIPPOCAMPUS; HUMAN; LIMBIC SYSTEM; MALE; MENTAL TASK; MESENCEPHALON; METHAMPHETAMINE DEPENDENCE; NEUROMODULATION; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT DECISION MAKING; PREFRONTAL CORTEX; PUTAMEN; RESTING STATE NETWORK; REWARD; RISK ASSESSMENT; BASAL GANGLION; CONNECTOME; DECISION MAKING; DEVICES; DRUG ABUSE; DRUG EFFECTS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY;

ADULT; AMPHETAMINE-RELATED DISORDERS; AMYGDALA; BASAL GANGLIA; CASE-CONTROL STUDIES; CONNECTOME; DECISION MAKING; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHAMPHETAMINE; PREFRONTAL CORTEX; RISK-TAKING;

EID: 84903978017     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2014.399     Document Type: Article

References (62)

1. Bechara A. Risky business: emotion, decision-making, and addiction. J Gambl Stud. 2003;19(1):23-51.
2. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia. 2001;39(4):376-389.
3. Gossop M, Griffiths P, Powis B, Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict. 1992;87(11):1527-1536.
4. Gossop M, Griffiths P, Powis B, Strang J. Severity of heroin dependence and HIV risk, I: sexual behaviour. AIDS Care. 1993;5(2):149-157.
5. Rogers RD, Everitt BJ, Baldacchino A, et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patientswith focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology. 1999;20(4):322-339.
6. Ernst M, Paulus MP. Neurobiology of decision making: a selective review from a neurocognitive and clinical perspective. Biol Psychiatry. 2005;58 (8):597-604.
7. Kohno M, Ghahremani DG, Morales AM, et al. Risk-Taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity [published online August 21, 2013]. Cereb Cortex.
8. Krain AL,Wilson AM, Arbuckle R, Castellanos FX, Milham MP. Distinct neural mechanisms of risk and ambiguity: ameta-analysis of decision-making. Neuroimage. 2006;32(1):477-484.
9. Rao H, KorczykowskiM, Pluta J, Hoang A, Detre JA. Neural correlates of voluntary and involuntary risk taking in the human brain: an fMRI study of the Balloon Analog Risk Task (BART). Neuroimage. 2008;42(2):902-910.
10. London ED, Simon SL, Berman SM, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004;61(1):73-84.
11. Morales AM, Lee B, Hellemann G, O'Neill J, London ED. Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug Alcohol Depend. 2012;125 (3):230-238.
12. Thompson PM, Hayashi KM, Simon SL, et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci. 2004;24(26):6028-6036.
13. Lee B, London ED, Poldrack RA, et al. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci. 2009;29(47):14734-14740.
14. Volkow ND, Chang L,Wang GJ, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry. 2001;158(12):2015-2021.
15. Wilson JM, Kalasinsky KS, Levey AI, et al. Striatal dopamine nerve terminal markers in human, chronicmethamphetamine users. Nat Med. 1996;2(6):699-703.
16. Wang GJ, Smith L, Volkow ND, et al. Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry. 2012;17 (9):918-925.
17. McCann UD,Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomgraphy studies with [11C]WIN-35,428. J Neurosci. 1998;18 (20):8417-8422.
18. FeltensteinMW, See RE. Systems level neuroplasticity in drug addiction. Cold Spring Harb Perspect Med. 2013;3(5):a011916.
19. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010;35(1): 217-238.
20. Fox MD, RaichleME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci. 2007;8(9): 700-711.
21. Gowin JL, Mackey S, Paulus MP. Altered risk-related processing in substance users: imbalance of pain and gain. Drug Alcohol Depend. 2013;132(1-2):13-21.
22. Lejuez CW, Read JP, Kahler CW, et al. Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J Exp Psychol Appl. 2002;8(2):75-84.
23. Bechara A, Dolan S, Hindes A. Decision-making and addiction (part II):myopia for the future or hypersensitivity to reward? Neuropsychologia. 2002;40(10):1690-1705.
24. Paulus MP, Hozack NE, Zauscher BE, et al. Behavioral and functional neuroimaging evidence for prefrontal dysfunction inmethamphetaminedependent subjects. Neuropsychopharmacology. 2002;26(1):53-63.
25. Paulus MP, Hozack N, Frank L, Brown GG, SchuckitMA. Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biol Psychiatry. 2003;53(1):65-74.
26. Galván A, Schonberg T, Mumford J, Kohno M, Poldrack RA, London ED. Greater risk sensitivity of dorsolateral prefrontal cortex in young smokers than in nonsmokers. Psychopharmacology (Berl). 2013;229(2):345-355.
27. Schonberg T, Fox CR, Mumford JA, Congdon E, Trepel C, Poldrack RA. Decreasing ventromedial prefrontal cortex activity during sequential risk-taking: an FMRI investigation of the balloon analog risk task. Front Neurosci. 2012;6:80.
28. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci. 2001;2(2):119-128.
29. Thomas MJ, Kalivas PW, Shaham Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol. 2008;154 (2):327-342.
30. White FJ, Hu XT, Zhang XF,Wolf ME. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther. 1995;273(1):445-454.
31. Chen BT, Hopf FW, Bonci A. Synaptic plasticity in themesolimbic system: therapeutic implications for substance abuse. Ann N Y Acad Sci. 2010;1187: 129-139.
32. Dean AC, Groman SM, Morales AM, London ED. An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology. 2013;38(2): 259-274.
33. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159(10):1642-1652.
34. Jentsch JD, Taylor JR. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl). 1999;146(4):373-390.
35. Konova AB, Moeller SJ, Tomasi D, Volkow ND, Goldstein RZ. Effects ofmethylphenidate on resting-state functional connectivity of the mesocorticolimbic dopamine pathways in cocaine addiction. JAMA Psychiatry. 2013;70(8):857-868.
36. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17(2):825-841.
37. Andersson J, Jenkinson M, Smith S. Non-Linear Registration, aka Spatial Normalisation: FMRIB Technical Report. Oxford, England: Oxford University; 2007.
38. Büchel C, Holmes AP, Rees G, Friston KJ. Characterizing stimulus-response functions using nonlinear regressors in parametric fMRI experiments. Neuroimage. 1998;8(2):140-148.
39. Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage. 2012;59(3):2142-2154.
40. Dean AC, Sugar CA, Hellemann G, London ED. Is all risk bad? young adult cigarette smokers fail to take adaptive risk in a laboratory decision-making test. Psychopharmacology (Berl). 2011;215(4): 801-811.
41. Hoffman WF, MooreM, Templin R, McFarland B, Hitzemann RJ,Mitchell SH. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology (Berl). 2006;188(2):162-170.
42. Monterosso JR, Ainslie G, Xu J, Cordova X, Domier CP, London ED. Frontoparietal cortical activity ofmethamphetamine-dependent and comparison subjects performing a delay discounting task. Hum Brain Mapp. 2007;28(5): 383-393.
43. Tanaka SC, Doya K, Okada G, Ueda K, Okamoto Y, Yamawaki S. Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops. Nat Neurosci. 2004;7(8):887-893.
44. Preuss TM. Do rats have prefrontal cortex? the Rose-Woolsey-Akert Program reconsidered. J Cogn Neurosci. 1995;7(1):1-24.
45. Brown VJ, Bowman EM. Rodent models of prefrontal cortical function. Trends Neurosci. 2002; 25(7):340-343.
46. Jentsch JD,Woods JA, Groman SM, Seu E. Behavioral characteristics and neural mechanisms mediating performance in a rodent version of the Balloon Analog Risk Task. Neuropsychopharmacology. 2010;35(8):1797-1806.
47. Doll BB, JacobsWJ, Sanfey AG, Frank MJ. Instructional control of reinforcement learning: a behavioral and neurocomputational investigation. Brain Res. 2009;1299:74-94.
48. Frank MJ. Computational models of motivated action selection in corticostriatal circuits. Curr Opin Neurobiol. 2011;21(3):381-386.
49. Ballard IC, Murty VP, Carter RM, MacInnes JJ, Huettel SA, Adcock RA. Dorsolateral prefrontal cortex drives mesolimbic dopaminergic regions to initiate motivated behavior. J Neurosci. 2011;31(28): 10340-10346.
50. Baker DA, McFarland K, Lake RW, et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci. 2003;6(7): 743-749.
51. Bamford NS, Zhang H, Joyce JA, et al. Repeated exposure tomethamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration. Neuron. 2008;58(1):89-103.
52. Robinson TE, Berridge KC. The neural basis of drug craving: an Incentive-Sensitization Theory of Addiction. Brain Res Brain Res Rev. 1993;18(3): 247-291.
53. Robinson TE, Berridge KC. Review: the Incentive Sensitization Theory of Addiction: some current issues. Philos Trans R Soc Lond B Biol Sci. 2008;363(1507):3137-3146.
54. Tindell AJ, Berridge KC, Zhang J, Peciña S, Aldridge JW. Ventral pallidal neurons code incentive motivation: amplification bymesolimbic sensitization and amphetamine. Eur J Neurosci. 2005;22(10):2617-2634.
55. Boileau I, Dagher A, Leyton M, et al. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry. 2006; 63(12):1386-1395.
56. Lett BT. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl). 1989;98(3):357-362.
57. Vezina P. Sensitization ofmidbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev. 2004;27(8):827-839.
58. Ward SJ, Läck C, Morgan D, Roberts DC. Discrete-trials heroin self-administration produces sensitization to the reinforcing effects of cocaine in rats. Psychopharmacology (Berl). 2006;185(2): 150-159.
59. Schonberg T, Fox CR, Poldrack RA.Mind the gap: bridging economic and naturalistic risk-taking with cognitive neuroscience. Trends Cogn Sci. 2011; 15(1):11-19.
60. Poldrack RA. Can cognitive processes be inferred from neuroimaging data? Trends Cogn Sci. 2006;10(2):59-63.
61. Knutson B, Adams CM, Fong GW, Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci. 2001;21(16):RC159.
62. Jensen J, McIntosh AR, Crawley AP,Mikulis DJ, Remington G, Kapur S. Direct activation of the ventral striatum in anticipation of aversive stimuli. Neuron. 2003;40(6):1251-1257.